These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35358480)

  • 1. Polymorphism in the human arylamine N-acetyltransferase 1 gene 3'-untranslated region determines polyadenylation signal usage.
    Choudhury C; Butcher NJ; Minchin RF
    Biochem Pharmacol; 2022 Jun; 200():115020. PubMed ID: 35358480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
    Endo Y; Yamashita H; Takahashi S; Sato S; Yoshimoto N; Asano T; Hato Y; Dong Y; Fujii Y; Toyama T
    BMC Cancer; 2014 Dec; 14():990. PubMed ID: 25528056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.
    Wang D; Para MF; Koletar SL; Sadee W
    Pharmacogenet Genomics; 2011 Oct; 21(10):652-64. PubMed ID: 21878835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
    Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
    Salazar-González RA; Turiján-Espinoza E; Hein DW; Niño-Moreno PC; Romano-Moreno S; Milán-Segovia RC; Portales-Pérez DP
    Arch Toxicol; 2018 Feb; 92(2):661-668. PubMed ID: 29043425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct.
    Millner LM; Doll MA; Stepp MW; States JC; Hein DW
    Carcinogenesis; 2012 Feb; 33(2):348-55. PubMed ID: 22114069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Arylamine N-acetyltransferase 1 and miR-1290 Levels in Childhood Acute Lymphoblastic Leukemia: A Pilot Study.
    Hernandez-Gonzalez O; Del Carmen Milan-Segovia R; Zavala-Reyes D; Alvarado-Zamarripa DM; Ortiz-Zamudio JJ; Correa-Gonzalez LC; Vargas-Morales JM; Uresti-Rivera EE; Portales-Perez DP
    In Vivo; 2023; 37(3):1129-1144. PubMed ID: 37103073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
    Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
    Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.
    Butcher NJ; Ilett KF; Minchin RF
    Pharmacogenetics; 1998 Feb; 8(1):67-72. PubMed ID: 9511183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas.
    Probst-Hensch NM; Haile RW; Li DS; Sakamoto GT; Louie AD; Lin BK; Frankl HD; Lee ER; Lin HJ
    Carcinogenesis; 1996 Oct; 17(10):2125-9. PubMed ID: 8895478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.
    Millner LM; Doll MA; Cai J; States JC; Hein DW
    Drug Metab Dispos; 2012 Jan; 40(1):198-204. PubMed ID: 22010219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions.
    Zhu Y; States JC; Wang Y; Hein DW
    Birth Defects Res A Clin Mol Teratol; 2011 Feb; 91(2):77-84. PubMed ID: 21290563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
    Minchin RF; Butcher NJ
    BMC Genomics; 2018 Jul; 19(1):513. PubMed ID: 29969986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
    Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
    BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue.
    Bell DA; Badawi AF; Lang NP; Ilett KF; Kadlubar FF; Hirvonen A
    Cancer Res; 1995 Nov; 55(22):5226-9. PubMed ID: 7585580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts.
    Boukouvala S; Sim E
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):343-51. PubMed ID: 15853926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.